Get the Stockscreener App
1.9999
1.01%
0.0199
Medicus Pharma Ltd stock is traded at $1.9999, with a volume of 32,675.
It is up +1.01% in the last 24 hours and down -25.93% over the past month.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
See More
Previous Close:
$1.98
Open:
$1.99
24h Volume:
32,675
Relative Volume:
0.10
Market Cap:
$43.62M
Revenue:
-
Net Income/Loss:
$-16.51M
P/E Ratio:
-1.4783
EPS:
-1.3528
Net Cash Flow:
$-15.68M
1W Performance:
-10.72%
1M Performance:
-25.93%
6M Performance:
-72.57%
1Y Performance:
-4.54%
1-Day Range:
$1.98
$2.00
1-Week Range:
$1.9028
$2.25
52-Week Range:
$1.7901
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Name
Medicus Pharma Ltd
Sector
Industry
Phone
610-540-7515
Address
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Compare MDCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
1.9999 | 43.62M | 0 | -16.51M | -15.68M | -1.3528 |
|
LLY
Lilly Eli Co
|
1,103.07 | 993.42B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
207.32 | 497.93B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
228.07 | 409.68B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
130.82 | 249.94B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
104.96 | 262.25B | 63.90B | 19.05B | 13.05B | 7.5596 |
Medicus Pharma Ltd Stock (MDCX) Latest News
Maxim Group Reaffirms Buy on Medicus Pharma Ltd (MDCX) With $20 Target - Insider Monkey
13 Best Canadian Penny Stocks to Buy Right Now - Insider Monkey
Small cap wrap: Medicus Pharma, Century Lithium, Aftermath Silver, Northstar Gold, First Phosphate… - Proactive financial news
Medicus Pharma explores novel treatment innovations for prostate, skin cancers - TipRanks
Medicus Pharma spotlights new approaches to prostate and skin cancer during Men’s Health Awareness Month - Proactive financial news
Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers - The Manila Times
Medicus Pharma Ltd. Explore Novel Treatment Innovations - GlobeNewswire
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - The Florida Times-Union
Medicus Pharma files to sell 2.68M common shares for holders - MSN
How buybacks impact Medicus Pharma Ltd. stock value2025 Price Momentum & Expert Approved Trade Ideas - newser.com
Why Medicus Pharma Ltd. (N460) stock attracts HNW investorsIPO Watch & Low Drawdown Investment Strategies - newser.com
What drives Medicus Pharma Ltd stock priceSwing Trading Ideas & Affordable Growth Trading - earlytimes.in
Why Medicus Pharma Ltd. Equity Warrant stock remains on watchlistsQuarterly Trade Summary & Verified Short-Term Plans - newser.com
Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights - Livingston Daily
Is Medicus Pharma Ltd. (N460) stock resilient in recession scenariosMarket Growth Summary & Growth-Oriented Investment Plans - newser.com
How Medicus Pharma Ltd. (N460) stock behaves under inflation pressure2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
Will Medicus Pharma Ltd. stock benefit from commodity pricesJuly 2025 Momentum & AI Powered Buy and Sell Recommendations - newser.com
How Medicus Pharma Ltd. (N460) stock gains from tech spendingJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Should I buy Medicus Pharma Ltd. (N460) stock before earnings seasonQuarterly Growth Report & High Accuracy Buy Signal Tips - newser.com
How institutional buying supports Medicus Pharma Ltd. stock2025 Dividend Review & Fast Gaining Stock Strategy Reports - newser.com
Published on: 2025-11-19 21:17:51 - newser.com
Published on: 2025-11-19 19:51:38 - newser.com
How strong is Medicus Pharma Ltd. Equity Warrant stock revenue growth - newser.com
How big funds are accumulating Medicus Pharma Ltd. (N460) stockPortfolio Risk Report & Safe Entry Zone Tips - newser.com
Can Medicus Pharma Ltd. stock maintain operating marginsSwing Trade & Reliable Intraday Trade Plans - newser.com
Is Medicus Pharma Ltd. (N460) stock a fit for income portfoliosJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Can Medicus Pharma Ltd. stock maintain growth trajectory - newser.com
Medicus Pharma Ltd Stock (MDCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.60%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):